Erstellt von fchar99
Insmed Inc. diskutieren
Insmed Inc.
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
136,00 €
-0,73 %
Insmed (NASDAQ:INSM) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $230.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Mizuho from $211.00 to $204.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target lowered by Wells Fargo & Company from $208.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Stifel Nicolaus from $205.00 to $208.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Bank of America Corporation from $211.00 to $213.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Leerink Partners from $210.00 to $215.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Mizuho from $204.00 to $206.00. They now have an "outperform" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by HC Wainwright from $230.00 to $245.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) had its price target raised by Barclays PLC from $231.00 to $237.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
Insmed (INSM) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $200.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
Neueste Beiträge
Morgan_Stanley in CNX Resources Corp. diskutieren